APA (7th ed.) Citation

ZA, W., KW, L., JG, K., C, D., JH, S., J, B., . . . SW, H. (2026). Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: The Phase II DeFianCe Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.CCR-26-1456

Chicago Style (17th ed.) Citation

ZA, Wainberg, et al. "Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: The Phase II DeFianCe Trial." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 2026. https://doi.org/10.1158/1078-0432.CCR-26-1456.

MLA (9th ed.) Citation

ZA, Wainberg, et al. "Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: The Phase II DeFianCe Trial." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 2026, https://doi.org/10.1158/1078-0432.CCR-26-1456.